167 related articles for article (PubMed ID: 30837090)
1. The ABO locus is associated with increased platelet aggregation in patients with stable coronary artery disease.
Christiansen MK; Larsen SB; Nyegaard M; Neergaard-Petersen S; Würtz M; Grove EL; Hvas AM; Jensen HK; Kristensen SD
Int J Cardiol; 2019 Jul; 286():152-158. PubMed ID: 30837090
[TBL] [Abstract][Full Text] [Related]
2. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
Larsen SB; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
[TBL] [Abstract][Full Text] [Related]
3. The ABO Locus is Associated with Increased Fibrin Network Formation in Patients with Stable Coronary Artery Disease.
Winther-Larsen A; Christiansen MK; Larsen SB; Nyegaard M; Neergaard-Petersen S; Ajjan RA; Würtz M; Grove EL; Jensen HK; Kristensen SD; Hvas AM
Thromb Haemost; 2020 Sep; 120(9):1248-1256. PubMed ID: 32604426
[TBL] [Abstract][Full Text] [Related]
4. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease.
Grove EL; Hvas AM; Mortensen SB; Larsen SB; Kristensen SD
J Thromb Haemost; 2011 Jan; 9(1):185-91. PubMed ID: 20955349
[TBL] [Abstract][Full Text] [Related]
5. Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease.
Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
PLoS One; 2015; 10(5):e0126767. PubMed ID: 25993271
[TBL] [Abstract][Full Text] [Related]
6. Calprotectin and platelet aggregation in patients with stable coronary artery disease.
Larsen SB; Grove EL; Pareek M; Kristensen SD; Hvas AM
PLoS One; 2015; 10(5):e0125992. PubMed ID: 25970343
[TBL] [Abstract][Full Text] [Related]
7. Platelet aggregation is dependent on platelet count in patients with coronary artery disease.
Würtz M; Hvas AM; Kristensen SD; Grove EL
Thromb Res; 2012 Jan; 129(1):56-61. PubMed ID: 21917303
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
9. 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease.
Henry P; Vermillet A; Boval B; Guyetand C; Petroni T; Dillinger JG; Sideris G; Bal dit Sollier C; Drouet L
Thromb Haemost; 2011 Feb; 105(2):336-44. PubMed ID: 21136023
[TBL] [Abstract][Full Text] [Related]
10. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
[TBL] [Abstract][Full Text] [Related]
11. Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention.
Ono T; Kaikita K; Hokimoto S; Iwashita S; Yamamoto K; Miyazaki Y; Horio E; Sato K; Tsujita K; Abe T; Deguchi M; Tayama S; Sumida H; Sugiyama S; Yamabe H; Nakamura S; Nakagawa K; Ogawa H
Thromb Res; 2011 Dec; 128(6):e130-6. PubMed ID: 21862109
[TBL] [Abstract][Full Text] [Related]
12. The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease.
Würtz M; Grove EL; Kristensen SD; Hvas AM
Heart; 2010 Mar; 96(5):368-71. PubMed ID: 19910291
[TBL] [Abstract][Full Text] [Related]
13. Platelet aggregation and P-selectin levels during exercise treadmill test in patients with ischaemic heart disease.
Kobusiak-Prokopowicz M; Kuliczkowski W; Karolko B; Prajs I; Mazurek W
Kardiol Pol; 2006 Oct; 64(10):1094-100; discussion 1101. PubMed ID: 17089241
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
[TBL] [Abstract][Full Text] [Related]
15. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
[TBL] [Abstract][Full Text] [Related]
16. Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction.
Larsen SB; Neergaard-Petersen S; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2012 Jul; 108(1):140-7. PubMed ID: 22534977
[TBL] [Abstract][Full Text] [Related]
17. Genetic determinants of on-aspirin platelet reactivity: focus on the influence of PEAR1.
Würtz M; Nissen PH; Grove EL; Kristensen SD; Hvas AM
PLoS One; 2014; 9(10):e111816. PubMed ID: 25360888
[TBL] [Abstract][Full Text] [Related]
18. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
[TBL] [Abstract][Full Text] [Related]
19. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.
Würtz M; Grove EL; Wulff LN; Kaltoft AK; Tilsted HH; Jensen LO; Hvas AM; Kristensen SD
JACC Cardiovasc Interv; 2010 Aug; 3(8):828-35. PubMed ID: 20723855
[TBL] [Abstract][Full Text] [Related]
20. Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease.
Pettersen AÅ; Arnesen H; Opstad TB; Bratseth V; Seljeflot I
Thromb Res; 2012 Sep; 130(3):424-8. PubMed ID: 22795340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
